Skip to search formSkip to main contentSkip to account menu

MultiStem

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Rationale MultiStem® (HLM051) is one of the promising allogenic cell products for acute ischemic stroke with strong evidence. A… 
2016
2016
I schemic stroke is caused by a blockage of blood flow to the brain. A leading cause of death and disability globally, each year… 
2016
2016
Introduction: MultiStem is an adult, adherent, stem cell product, having shown safety and efficacy in other clinical… 
2016
2016
MultiStem cells are clinical‐grade multipotent adult bone marrow‐derived progenitor cells (MAPCs), with extensive replication… 
Highly Cited
2014
Highly Cited
2014
Background There is growing interest in neurorestorative and reparative therapies after acute stroke. MultiStem® is an allogeneic… 
Review
2012
Review
2012
The last decade has seen much progress in adjunctive cell therapy for immune disorders. Both corporate and institutional Phase… 
Highly Cited
2012
Highly Cited
2012
Rationale: MultiStem is an allogeneic bone marrow–derived adherent adult stem cell product that has shown efficacy in preclinical… 
2010
2010
Highly Cited
2009
Highly Cited
2009
The therapeutic benefits of adult adherent stem cells are currently being investigated in clinical trials for a variety of… 
Highly Cited
2004
Highly Cited
2004
The ecology and evolutionary potential of coast redwood (Sequoia sempervirens) is significantly influenced by the important role…